有蛋糕和吃它吗? 克洛法西明可以增强免疫疗法,同时限制副作用
Lukas Kraehenbuehl1, Jedd D Wolchok2, Taha Merghoub3
1Pharmacology Program, Weill Cornell Graduate School, New York, NY, USA; Swim Across America and Ludwig Collaborative Laboratory, Department of Pharmacology, Weill Cornell Medical Center, New York, NY, USA; Sandra and Edward Meyer Cancer Center, Weill Cornell Medical Center, New York, NY, USA; Department of Dermatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
抗菌药物克洛法齐明 (clofazimine) 提高了癌症免疫治疗的有效性,同时减少了有害的副作用. 这一发现为改善联合免疫检查点阻塞 (ICB) 治疗提供了一个有希望的策略.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 综合免疫检查点封锁 (ICB) 在一些癌症患者中显示出有效性.
- ICB治疗与免疫相关的不良事件有关.
- 需要新的策略来提高ICB的有效性和安全性.
研究的目的:
- 识别那些可以增强ICB疗效的药物.
- 寻找能够减轻ICB相关免疫相关不良事件的药物.
主要方法:
- 使用一种药物查策略.
- 研究了已识别的化合物对ICB的影响.
- 评估了对疗效和不良事件的影响.
主要成果:
- 确定了抗菌药物克洛法齐明.
- 发现克洛法齐明可以增强ICB的疗效.
- 克洛法西明还减少了与免疫相关的不良事件.
结论:
- 克洛法齐明是一种潜在的治疗药物,可以改善联合免疫检查点阻塞.
- 这一发现为癌症免疫疗法提供了增强疗效和降低毒性的双重好处.
相关概念视频
Tumor Immunotherapy
Targeted Cancer Therapies
There are several types of targeted therapies against...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Combined Effects of Drugs: Synergism
Such synergistic combinations...


